Your browser doesn't support javascript.
loading
High-Dose FOLFIRI plus Bevacizumab in the Treatment of Metastatic Colorectal Cancer Patients with Two Different UGT1A1 Genotypes: FFCD 0504 Study.
Manfredi, Sylvain; Bouché, Olivier; Rougier, Philippe; Dahan, Laetitia; Loriot, Marie Anne; Aparicio, Thomas; Etienne, Pierre Luc; Lafargue, Jean Pierre; Lécaille, Cedric; Legoux, Jean Louis; Le Malicot, Karine; Maillard, Emilie; Lecomte, Thierry; Khemissa, Faiza; Breysacher, Gilles; Michel, Pierre; Mitry, Emmanuel; Bedenne, Laurent.
Afiliação
  • Manfredi S; Hepato-Gastroenterology and Digestive Oncology Department, University Hospital Dijon, INSERM U 866, Digestive Cancer Registry of Burgundy, Dijon, France. Fédération Francophone de Cancérologie Digestive, INSERM U866, Dijon, France. sylvain.manfredi@gmail.com.
  • Bouché O; Department of Gastroenterology, CHU Robert Debré, Reims, France.
  • Rougier P; Assistance Publique Hôpitaux de Paris, Hôpital Européen G Pompidou and Université Paris Descartes, Paris, France.
  • Dahan L; Department of Gastroenterology, Assistance Publique - Hôpitaux de Marseille, Hôpital la Timone, et Aix-Marseille Université, Marseille, France.
  • Loriot MA; Assistance Publique Hôpitaux de Paris, Hôpital Européen G Pompidou and Université Paris Descartes, Paris, France.
  • Aparicio T; Department of Gastroenterology and Digestive Oncology, Avicenne Hospital, HUPSSD, APHP and University Paris 13, Bobigny, France.
  • Etienne PL; Department of Medical Oncology, Clinique Armoricaine de Radiologie, St-Brieuc, France.
  • Lafargue JP; Department of Gastroenterology, Centre Hospitalier, La Roche sur Yon, France.
  • Lécaille C; Department of Gastroenterology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France.
  • Legoux JL; Department of Gastroenterology, Centre Hospitalier Régional, Orléans, France.
  • Le Malicot K; Fédération Francophone de Cancérologie Digestive, INSERM U866, Dijon, France.
  • Maillard E; Fédération Francophone de Cancérologie Digestive, INSERM U866, Dijon, France.
  • Lecomte T; Department of Gastroenterology, CHU de Tours and Université François Rabelais, Chambray les Tours, France.
  • Khemissa F; Department of Gastroenterology, Centre Hospitalier, Perpignan, France.
  • Breysacher G; Department of Gastroenterology, Hôpitaux Civils, Colmar, France.
  • Michel P; Department of Gastroenterology, Rouen University Hospital and University of Rouen, Rouen, France.
  • Mitry E; Department of Medical Oncology, Institut Curie, Paris - St. Cloud and Université Versailles St. Quentin, UFR des Sciences de la Santé, Saint Cloud, France.
  • Bedenne L; Hepato-Gastroenterology and Digestive Oncology Department, University Hospital Dijon, INSERM U 866, Digestive Cancer Registry of Burgundy, Dijon, France. Fédération Francophone de Cancérologie Digestive, INSERM U866, Dijon, France.
Mol Cancer Ther ; 14(12): 2782-8, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26494856
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Glucuronosiltransferase / Bevacizumab Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Glucuronosiltransferase / Bevacizumab Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França